OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis

Cancer Science

Volumn 98, Issue 1, 2007, Pages 50-57

  Ishiyama, Tadashi ^a   Kano, Junko ^a   Anami, Yoichi ^a   Onuki, Takuya ^a   Iijima, Tatsuo ^a   Morisita, Yukio ^a   Yokota, Jun ^b   Noguchi, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; GALAPTIN; LECTIN; LIPOCORTIN 2; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN OCIA DOMAIN CONTAINING 2; STAT PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; NORTHERN BLOTTING; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TUMOR CELL;

ADENOCARCINOMA; AGED; BLOTTING, NORTHERN; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33751348583     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00346.x     Document Type: Article

References (29)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
2. Park I-W, Wistuba II, Maitra A et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst 1999; 91: 1863-8.
3. Noguchi M, Morikawa A, Kawasaki M et al. Small adenocarcinoma of the lung. Cancer 1995; 75: 2844-52.
4. Minami Y, Matsuno Y, Iijima T et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 2005; 48: 339-48.
5. Suzuki K, Yokose T, Yoshida J et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000; 69: 893-7.
6. Yokose T, Suzuki K, Nagai K, Nishiwaki Y, Sasaki S, Ochiai A. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 2000; 29: 179-88.
7. Sakurai H, Maeshima A, Watanabe S et al. Grade of stromal invasion in small adenocarcinoma: Histopathological minimal invasion and prognosis. Am J Surg Pathol 2004; 28: 198-206.
8. Aoyagi Y, Yokose T, Minami Y et.al. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma. Cancer Res 2001; 61: 7950-4.
9. Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E. Survivin expression in atypical adenomatous hyperplasia of the lung. Am J Clin Pathol 2003; 120: 712-19.
10. Saad RS, Liu Y, Han H, Landreneau RJ, Silverman JF. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol 2004; 17: 1235-42.
11. Ghazizadeh M, Jin E, Shimizu H et al. Role of cdk4, 16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Respiration 2005; 72: 68-73.
12. Kerr KM, MacKenzie SJ, Ramasami S et al. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol 2004; 203: 638-44.
13. Beer DG, Kardia SL, Huang CC et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816-24.
14. Borczuk AC, Kim HK, Yegen HA, Friedman RA, Powell CA. Lung adenocarcinoma global profiling identifies type II transforming growth factor-β receptor as a repressor of invasiveness. Am J Respir Crit Care Med 2005; 172: 729-37.
15. Berrar D, Sturgeon B, Bradbury I, Downes CS, Dubitzky W. Survival trees for analyzing clinical outcome in lung adenocarcinomas based on gene expression profiles: Identification of neogenin and diacylglycerol kinase alpha expression as critical factors. J Comput Biol 2005; 12: 534-44.
16. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumours, 3rd edn. World Health Organization International Histological Classification of Tumours. Berlin: Springer, 1999.
17. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-17.
18. Aoyagi K, Tatsuta T, Nishigaki M et al. A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem Biophys Res Commun 2003; 300: 915-20.
19. Buccheri G. Circulating biomarkers for lung cancer. Ann Ital Chir 1999; 70: 831-8.
20. Kitamura H, Kameda Y, Nakamura N et.al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996; 20: 553-62.
21. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003; 88: 848-54.
22. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997; 74: 464-9.
23. Went PT, Lugli A, Meier S et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004; 35: 122-8.
24. Went P, Vasei M, Bubendorf L et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006; 94: 128-35.
25. Kornberg A, Pricer WE Jr. Enzymatic synthesis of the coenzyme A derivatives of long chain fatty acids. J Biol Chem 1953; 204: 329-43.
26. Kim JH, Lewin TM, Coleman RA. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5: Selective inhibition by triacsin C and thiazolidinediones. J Biol Chem 2001; 276: 24 667-73.
27. Hesler CB, Olymbios C, Haldar D. Transverse-plane topography of long-chain acyl-CoA synthetase in the mitochondrial outer membrane. J Biol Chem 1990; 265: 6600-5.
28. Strausberg RL, Feingold EA, Grouse LH et al. Mammalian Gene Collection Program Team. Generation and initial analysis of more than 15 000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 2002; 99: 16 899-903.
29. Luo LY, Soosaipillai A, Diamandis EP. Molecular cloning of a novel human gene on chromosome 4p11 by immunoscreening of an ovarian carcinoma cDNA library. Biochem Biophys Res Commun 2001; 280: 401-6.